Mabtech

Mabtech company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are a Swedish company developing immunoassays for life science research. Our goal is to aid research by providing the scientific community with innovative tools, in particular for ELISpot, FluoroSpot, and ELISA. To that end, we develop and produce a wide range of monoclonal antibodies, kits, peptide pools, and instruments for in vitro applications. We started off in Stockholm in 1986, and our headquarters still lies in Nacka Strand, just east of the inner city. We do everything here, from research and production to finance, IT, quality control, marketing, distribution, and sales. In addition, we have a sales office in Cincinnati, Ohio, and collaborate with great distributors around the globe. The quality of our products really comes down to our entire organization; the balance between individual action and care for the collective. Because for us, quality isn’t just a word. It’s a mindset, a mantra, and a lens we hold to all our initiatives, whatever the size. As part of the scientific community, we want to do our share to help science progress. So we hope you see us as peers – feel free to strike up any sort of conversation with us.

Company Details

Employees
128
Founded
-
Address
Augustendalstorget 9, Nacka Strand,stockholm County 131 52,sweden
Phone
+46 8 716 27 00
Email
ma****@****ech.com
Industry
Research
HQ
Nacka Strand, Stockholm County
Looking for a particular Mabtech employee's phone or email?

Mabtech Questions

News

EQT and Mabtech Transaction - William Blair

EQT and Mabtech Transaction William Blair

White & Case advises IK Partners on sale of Mabtech to EQT Healthcare Growth Strategy - White & Case LLP

White & Case advises IK Partners on sale of Mabtech to EQT Healthcare Growth Strategy White & Case LLP

EQT Launches New Health-Care Growth Strategy and Buys Mabtech - Bloomberg.com

EQT Launches New Health-Care Growth Strategy and Buys Mabtech Bloomberg.com

EQT introduces the EQT Healthcare Growth Strategy, a dedicated healthcare buyout strategy, with the acquisition of life sciences tools company Mabtech - Cision News

EQT introduces the EQT Healthcare Growth Strategy, a dedicated healthcare buyout strategy, with the acquisition of life sciences tools company Mabtech Cision News

Comparison of immunogenicity and safety of inactivated, adenovirus-vectored and heterologous adenovirus-vectored/mRNA vaccines in patients with systemic lupus erythematosus and rheumatoid arthritis: a prospective cohort study - medRxiv

Comparison of immunogenicity and safety of inactivated, adenovirus-vectored and heterologous adenovirus-vectored/mRNA vaccines in patients with systemic lupus erythematosus and rheumatoid arthritis: a prospective cohort study medRxiv

EQT finds ‘perfect fit’ for new strategy with Mabtech acquisition - pehub.com

EQT finds ‘perfect fit’ for new strategy with Mabtech acquisition pehub.com

Sweden: IK Investment to acquire Mabtech - Investors in Healthcare

Sweden: IK Investment to acquire Mabtech Investors in Healthcare

Top Mabtech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant